Human Reproduction, Vol. 15, No. 7, 1624-1628,
July 2000
© 2000 European Society of Human Reproduction and Embryology
Increased fetal erythroblasts in women who subsequently develop pre-eclampsia
1 Harris Birthright Research Centre for Fetal Medicine and 2 Department of Haematological Medicine, King's College Hospital, London, UK
In pregnancies complicated by pre-eclampsia (PET) and/or intrauterine growth restriction (IUGR) there is an increased number of fetal cells in the maternal circulation. The aim of this study was to investigate whether this increase in fetal cells precedes the onset of these pregnancy complications. Doppler ultrasound studies at 24 weeks gestation have shown that increased impedance to flow in the uterine arteries identifies pregnancies with impaired placental perfusion that subsequently develop PET and/or IUGR. We obtained maternal blood from 18 pregnancies with abnormal Doppler results at 22–24 weeks gestation and from 10 normal controls. Fetal erythroblasts were enriched from maternal blood by triple density gradient centrifugation and magnetic cell sorting with CD71 antibody, and the percentage of these erythroblasts was determined. The median proportion of fetal erythroblasts in the group with abnormal Doppler results was 4.5% (range 1–12%), which was significantly higher than in the control group [median 1% (range 0–3%; P < 0.001)]. Furthermore, within the group with abnormal Doppler the median proportion of fetal erythroblasts was higher in the 10 cases which subsequently developed PET and/or IUGR [median 5.5% (range 3–12%)], than in those with normal pregnancy outcome [median 2% (range 1–5%; P < 0.01)]. These findings suggest that impaired placental perfusion is associated with an increase in feto-maternal cell traffic, which precedes the onset of PET and/or IUGR by several weeks.
Key words: Doppler ultrasound/fetal cells in maternal blood/intrauterine growth restriction/pre-eclampsia/screening
3 To whom correspondence should be addressed at: Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, Denmark Hill, London SE5 8RX, UK
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Mavrou, A. Kolialexi, A. Souka, A. Pilalis, Y. Kavalakis, P. Antsaklis, E. Kanavakis, and A. Antsaklis First-trimester NRBC Count in Maternal Circulation: Correlation with Doppler Ultrasound Studies J. Histochem. Cytochem., March 1, 2005; 53(3): 315 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fernandez, B. Prieto, A. Escudero, J. H. Ladenson, and F. V. Alvarez A Monoclonal Antibody with Potential for Aiding Non-invasive Prenatal Diagnosis: Utility in Screening of Pregnant Women at Risk of Preeclampsia J. Histochem. Cytochem., March 1, 2005; 53(3): 345 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Al-Mufti, H. Hambley, F. Farzaneh, and K. H. Nicolaides Distribution of fetal erythroblasts enriched from maternal blood in multifetal pregnancies Hum. Reprod., September 1, 2003; 18(9): 1933 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Y. Zhong, W. Holzgreve, and S. Hahn Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts Mol. Hum. Reprod., September 1, 2002; 8(9): 864 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. N. Leung, J. Zhang, T. K. Lau, L. Y.S. Chan, and Y.M. D. Lo Increased Maternal Plasma Fetal DNA Concentrations in Women Who Eventually Develop Preeclampsia. Clin. Chem., January 1, 2001; 47(1): 137 - 139. [Full Text] [PDF]
|
|
|
|
|
|
Y.M. D. Lo Fetal DNA in Maternal Plasma: Biology and Diagnostic Applications Clin. Chem., December 1, 2000; 46(12): 1903 - 1906. [Abstract] [Full Text] [PDF]
|
|